Pages that link to "Q35050475"

The following pages link to Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort (Q35050475):

Displaying 20 items.

• Vimentin DNA methylation predicts survival in breast cancer (Q34034767) (← links)
• Promoter hypermethylation profiling of distant breast cancer metastases (Q35533772) (← links)
• Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk (Q35942162) (← links)
• Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls (Q36402760) (← links)
• Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients (Q36622838) (← links)
• DNA methylation in ductal carcinoma in situ of the breast (Q36998647) (← links)
• Quantitation of CDH1 promoter methylation in formalin-fixed paraffin-embedded tissues of breast cancer patients using differential high resolution melting analysis (Q37006733) (← links)
• DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection (Q37269445) (← links)
• Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns (Q37321765) (← links)
• PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy (Q37367387) (← links)
• DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk. (Q37655029) (← links)
• Host Factors and Risk of Breast Cancer Recurrence: Genetic, Epigenetic and Biologic Factors and Breast Cancer Outcomes (Q38522986) (← links)
• Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2. (Q39204978) (← links)
• Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients (Q39287409) (← links)
• Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients (Q40979375) (← links)
• Oral Contraceptive Use May Modulate Global Genomic DNA Methylation and Promoter Methylation of APC1 and ESR1 (Q47134189) (← links)
• Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008. (Q50055284) (← links)
• Aberrant methylation of APC and RARβ2 genes in breast cancer patients. (Q53809194) (← links)
• Validation of DNA promoter hypermethylation biomarkers in breast cancer — a short report (Q60529799) (← links)
• DNA Methylation Markers for Breast Cancer Detection in the Developing World (Q91838904) (← links)